CN213589482U - Uterine balloon catheter and medical assembly - Google Patents

Abstract

The utility model provides a uterus sacculus pipe and medical subassembly, uterus sacculus pipe includes pipe body and sacculus, the sacculus sets up in the distal end of pipe body, the pipe body has sufficient chamber and dosing chamber, through sufficient chamber to the sacculus transport sufficient medium, and through dosing chamber carry the medicine to the surface of sacculus; the balloon is matched with the shape of the intrauterine cavity after being inflated. The utility model discloses a uterus sacculus pipe and medical treatment subassembly the shape after the sacculus is full and the shape phase-match of uterus inner chamber help evenly dosing.

Description

Uterine balloon catheter and medical assembly

Technical Field

The utility model relates to the field of medical equipment, concretely relates to uterus sacculus pipe and medical subassembly.

Background

In clinical therapy, intrauterine administration is one of the most important therapeutic modalities. Intrauterine administration is a therapeutic procedure that utilizes an administration vehicle to enter the uterine cavity from the cervical orifice and deliver the drug. Intrauterine administration has a wide range of applications, such as the injection of drugs with hemostatic and reparative functions into the uterine lumen in case of Abnormal Uterine Bleeding (AUB).

The existing treatment modes need to uniformly and quickly deliver the medicine to the uterine cavity, and in most cases, the medicine needs to be effectively utilized, so that the waste is reduced as much as possible. The drug delivery carrier on the market at present has various defects, for example, a uterine balloon catheter on the market comprises a catheter body and a balloon located at the far end of the catheter body, the balloon is of a double-layer structure, a doctor injects a filling medium into the balloon through a filling cavity of the catheter body to enable the balloon to be filled according to the shape of an uterine cavity, medicines are filled between interlayers of an inner balloon and an outer balloon through a drug delivery cavity of the catheter body, the balloon located on the outer layer is provided with an outlet, and the filled medicines flow out from the outlet of the outer balloon to act on the endometrium.

Wherein, can't attach in uterus inner wall betterly after the sacculus is full, the medicine easily directly runs off between the surface of sacculus and uterus inner wall, can't evenly administer, and the medicine utilization ratio is low. In addition, the double-layer structure of the balloon leads to larger overall outer diameter of the uterine balloon catheter, and particularly the balloon part is difficult to pass through the cervical orifice and can damage the cervix. The dosage of the double-layer balloon administration mode is also large, the medicine needs to be completely filled between interlayers of the balloons, and a large amount of medicine can be retained in the interlayers, so that waste is caused.

SUMMERY OF THE UTILITY MODEL

The utility model aims at providing a uterus sacculus pipe and medical subassembly can realize that the uterus is interior to be dosed, and it is even and the drug utilization ratio is higher to dose.

In order to achieve the above object, according to a first aspect of the present invention, there is provided a uterine balloon catheter, comprising a catheter body and a balloon, wherein the balloon is disposed at a distal end of the catheter body, the catheter body has a filling cavity and a drug delivery cavity, a filling medium is delivered to the balloon through the filling cavity, and a drug is delivered to an outer surface of the balloon through the drug delivery cavity; the balloon is matched with the shape of the intrauterine cavity after being inflated.

Optionally, the balloon is spherical, ellipsoidal or triangular in shape after filling.

Optionally, the outer surface of the balloon is provided with a coating configured to match the characteristics of the drug to cause the drug to wet-diffuse along the outer surface of the balloon.

Optionally, the balloon is a single-layer balloon, or the balloon is a double-layer balloon, and the outer surface of the outer-layer balloon is provided with the coating.

Optionally, the distal end of the catheter body is provided with at least one drug delivery port, and the drug delivery port is communicated with the drug delivery cavity and used for delivering drugs to the outer surface of the balloon.

Optionally, when the medicament is Jinlinging, the aperture of the administration port is configured to be 1.5 mm-2.0 mm.

Optionally, the number of the administration ports is multiple, and the administration ports are arranged at intervals along the axial direction and/or the circumferential direction of the catheter body.

According to a second aspect of the present invention, there is provided a medical assembly comprising a uterine balloon catheter and a sheath according to any of the aspects of the present invention; the uterine balloon catheter is used for loading in the sheath so as to convey the uterine balloon catheter through the sheath.

Optionally, the medical assembly further includes a fixing member, the fixing member is disposed at the proximal end of the sheath, and is configured to fix a relative position of the sheath and the catheter.

Optionally, the distal end of the sheath is provided with a scale mark.

Optionally, the guide wire comprises a guide wire body and a locking joint, the length of the guide wire body is shorter than that of the uterine balloon catheter, and the locking joint is located at the proximal end of the guide wire body and used for preventing the proximal end of the guide wire body from being embedded into the uterine balloon catheter.

The utility model provides a uterus sacculus pipe and medical component include the pipe body and be located the sacculus of pipe body distal end, the pipe body has sufficient chamber and the chamber of dosing, sufficient chamber is used for filling the sacculus, the chamber of dosing is used for carrying medicine to sacculus surface to have following advantage:

first, the utility model discloses a sacculus is full back and the shape phase-match of uterus inner chamber to can attach in uterus inner chamber, help dosing uniformity and improve the drug utilization rate.

Second, the utility model discloses a surface of sacculus has the coating, can make the medicine soak the diffusion along the surface of sacculus, consequently can further promote evenly to administer and improve the drug utilization rate.

Third, because the surface of sacculus has above-mentioned coating, the utility model discloses a sacculus is preferably individual layer sacculus, compares with prior art's double-deck sacculus, and the medicine directly acts on the endometrium through the sacculus surface, does not flow through the medicine loss that the intermediate layer caused, has improved the medicine utilization ratio, and the surface of sacculus has the coating, can make the medicine soak the diffusion along the surface of sacculus, consequently can evenly dose. The whole external diameter after the single-layer saccule is folded is also smaller, so that the single-layer saccule can easily pass through the cervical orifice, and the probability of cervical injury is reduced.

In addition, when the balloon is used for hemostasis by compression or preventing uterine cavity adhesion and the filling pressure required in the balloon is large, the single-layer balloon avoids the problem that the administration is difficult because the interlayer of the double-layer balloon is compressed. Particularly when high-viscosity gel drugs are administered, the single-layer balloon cannot obstruct the flow of the drugs due to the limited interlayer space, so that the administration is difficult. The single-layer balloon also has better compliance and good adherence effect, can better conform to the change of the shape of the uterine cavity, and can improve the release rate of the medicament.

Fourth, the utility model discloses a length of seal wire body weak point is in uterus sacculus pipe, can prevent that the distal end of seal wire from stabbing uterus sacculus pipe and uterus wall, and the near-end of seal wire body has the locking joint, can prevent the near-end tip of seal wire body is buried uterus sacculus pipe's inside conveniently takes out the seal wire.

Drawings

Those skilled in the art will appreciate that the drawings are provided for a better understanding of the invention and do not constitute any limitation on the scope of the invention. Wherein:

fig. 1 is a schematic structural view of a uterine balloon catheter of a medical assembly according to an embodiment of the present invention;

fig. 2 is a schematic view of a guide wire of a medical assembly according to an embodiment of the present invention;

fig. 3a-3e are schematic structural views of an administration port of a uterine balloon catheter according to an embodiment of the present invention;

fig. 4a-4c are schematic structural views of a balloon according to an embodiment of the present invention.

Description of reference numerals:

100-uterine balloon catheter; 101-a connector; 1011-filling branch; 1012-administration branch; 102-a catheter body; 1021-filling the lumen; 1022-a dosing chamber; 1023-an administration port; 103-balloon; 104-sheath; 105-a fixture; 106-a guide wire; 1061-a guidewire body; 1062-locking the joint.

Detailed Description

In order to make the contents of the present invention more clearly understood, the present invention will be further described with reference to the drawings and the following embodiments. It is to be understood that the invention is not limited to the particular embodiments described below, and that general alternatives known to those skilled in the art are intended to be included within the scope of the invention. It should be noted that the drawings are in simplified form and are not to precise scale, and are provided for convenience and clarity in order to facilitate the description of the embodiments of the present invention.

It should be understood that in the following description, references to "upper" and "lower" components may be made based on the accompanying drawings. Spatial terms such as "below …", "below …", "below", "above", and the like are intended to facilitate describing the positional relationship of one element to another element as illustrated in the figures, and may encompass a variety of different orientations of the device in use or operation in addition to the orientation depicted in the figures. The device may be otherwise oriented, such as rotated 90 degrees or at other orientations, and the spatially relative descriptors used herein interpreted accordingly.

It should also be understood that in the following description, "proximal" and "distal" are relative orientations, relative positions, directions of elements or actions with respect to each other from the perspective of a clinician using the medical device, and although "proximal" and "distal" are not intended to be limiting, "proximal" generally refers to the end of the medical device that is closer to the clinician during normal operation, and "distal" generally refers to the end that is first introduced into a patient.

The utility model discloses a core thought provides a uterus sacculus pipe and medical treatment subassembly for intrauterine drug delivery, include the pipe body and be located the sacculus of pipe body distal end, the pipe body has sufficient chamber and the chamber of dosing, sufficient chamber is used for filling the sacculus, the chamber of dosing is used for carrying medicine to the sacculus surface, the sacculus is full back and intrauterine shape phase-match, consequently, the medicine can be followed the surface of sacculus and acted on the endometrium better, helps evenly dosing and improvement drug utilization. In particular, the outer surface of the balloon is provided with a coating, and the coating is matched with the characteristics of the drug, so that the drug is infiltrated and diffused along the outer surface of the balloon, and uniform drug administration can be further promoted and the drug utilization rate can be further improved.

The uterine balloon catheter and medical assembly of an embodiment of the present invention will be described in detail with reference to the accompanying fig. 1-4c and the following detailed description.

Please refer to fig. 1, which is a schematic structural diagram of a uterine balloon catheter 100 in a medical assembly according to an embodiment of the present invention. As shown in fig. 1, the medical assembly includes a uterine balloon catheter 100. Uterus balloon catheter 100 includes catheter body 102 and balloon 103, and balloon 103 sets up at the distal end of catheter body 102, and catheter body 102 has filling chamber 1021 and administration chamber 1022 to carry filling medium to balloon 103 through filling chamber 1021, and balloon 103 is matched with the intrauterine cavity shape after filling, can adhere to the endometrium, in order to carry the medicine to the surface of balloon 103 through administration chamber 1022, makes the medicine flow along balloon 103's surface and open, thereby acts on the endometrium.

The outer surface of balloon 103 is preferably provided with a coating matching the properties of the drug, by means of which the drug can be diffused along the outer surface of balloon 103. For example, the coating has wettability, where wettability refers to the property of the coating matching the drug injected into the administration lumen 1022, which can achieve the effect of infiltrating the drug, allowing the drug to infiltrate and spread along the outer surface of the balloon 103, and to homogenize the endometrium. Illustratively, such as a Jincorning drug for hemostasis, the coating of the outer surface of balloon 103 may be a hydrophilic coating, such as a PVP (polyvinyl pyrrolidone) coating, to achieve rapid infiltration of the Jincorning drug at the outer surface of balloon 103.

In this embodiment, the balloon 103 is preferably a single-layer balloon, and since an interlayer between the inner and outer balloon layers does not need to be filled in advance, the amount of the drug can be reduced, and the drug utilization rate can be improved. The single-layer balloon has remarkable effect particularly when the cost of treatment medicines is high, and can effectively reduce the medical cost and lighten the burden of patients. In particular, the coated single layer balloon 103 is suitable for delivery of drugs such as hemostatic drugs (e.g., Jinlingning) into the uterus.

However, in some applications, a double-layered balloon with a coating may also be used. For example, the problem of low drug availability due to filling the interlayer with a large amount of drug is not considered when the cost of the drug is low. Again, for example, when compression hemostasis with balloon 103 is not required or adhesion of the uterine cavity is prevented, the inflation pressure of balloon 103 will not be too great to compress the interlayer space between the inner and outer balloon layers, thereby preventing the drug from filling the interlayer.

Thus, in another exemplary embodiment, balloon 103 is a double-layer balloon, comprising an inner balloon and an outer balloon, the outer balloon being positioned outside the inner balloon and having at least one outlet port, and administration lumen 1022 being in communication with the interlayer of the double-layer balloon. The outer surface of the outer balloon is provided with a corresponding coating, the medicine delivered through the administration cavity 1022 firstly flows into an interlayer between the outer balloon and the inner balloon, then flows out through the outlet of the outer balloon and is diffused along the outer surface of the outer balloon, and the number of the outlets can be set to be multiple for realizing uniform diffusion of the medicine. In the process, the medicine is uniformly distributed for the first time through the interlayer between the inner balloon layer and the outer balloon layer, and then is uniformly distributed for the second time through the coating diffusion on the outer surface of the outer balloon layer, so that the medicine can more uniformly act on the endometrium.

With continued reference to fig. 1, the uterine balloon catheter 100 of the present embodiment further includes a connector 101, the connector 101 being located at the proximal end of the catheter body 102 for connection with an external device, such as a medical syringe, for delivering the drug and the inflation medium. Optionally, the balloon 103, the catheter body 102 and the connecting member 101 may be connected by thermal welding, which is not limited by the present invention.

Further, the filling lumen 1021 has an inlet at the proximal end of the catheter body 102 and an outlet at the distal end of the catheter body 102. Administration lumen 1022 also has an inlet at the proximal end of catheter body 102 and an outlet at the distal end of catheter body 102, the outlet of administration lumen 1022 communicating with administration port 1023 at the distal end of catheter body 102. Connector 101 includes an inflation branch 1011 and an administration branch 1012. Wherein, the filling branch 1011 is communicated with the inlet of the filling cavity 1021 for filling the balloon 103, and the administration branch 1012 is communicated with the inlet of the administration cavity 1022 for delivering the medicine. Since the outer surface of balloon 103 is provided with a coating, the drug flowing out of drug administration port 1023 can infiltrate and diffuse along the outer surface of balloon 103, thereby uniformly acting on the endometrium.

With continued reference to fig. 1, the medical assembly of the present embodiment further includes a sheath 104 for loading and delivering the uterine balloon catheter 100. Specifically, the uterine balloon catheter 100 is loaded in the sheath 104, and the uterine balloon catheter 100 is guided by the sheath 104 to enter the uterine lumen from the cervical orifice. The medical assembly may further comprise a fixing member 105, the fixing member 105 being located at the proximal end of the sheath 104 for fixing the relative position of the sheath 104 and the uterine balloon catheter 100, preventing the uterine balloon catheter 100 from slipping. The distal end of the sheath 104 can be provided with a scale mark, and the length of the scale mark can be set to be 4cm-10cm, so as to conveniently judge the size and the position of the uterine balloon catheter 100 entering the uterine cavity. Preferably, the sheath 104 is made of a material with a low friction coefficient, such as one or a combination of PTFE, FEP, and HDPE.

Please refer to fig. 2, which is a schematic structural diagram of a guide wire 106 of a medical assembly according to an embodiment of the present invention. As shown in fig. 2, optionally, the medical assembly of the present invention further includes a guide wire 106, wherein the guide wire 106 is configured to be movably inserted into the uterus balloon catheter 100, for example, the guide wire 106 is inserted into the uterus balloon catheter 100 from the proximal end of the uterus balloon catheter 100, and is configured to support the uterus balloon catheter 100 from the cervical opening into the uterine cavity. Preferably, the guide wire 106 includes a guide wire body 1061, and the length of the guide wire body 1061 is shorter than that of the uterine balloon catheter 100, so as to prevent the guide wire body 1061 from damaging the distal end and cervix of the uterine balloon catheter 100. And the proximal end of the guide wire body 1061 can be provided with a locking joint 1062, and the locking joint 1062 is wider than the opening of the proximal end of the uterine balloon catheter 100, so that the proximal end of the guide wire body 1061 is prevented from being embedded in the uterine balloon catheter 100, and the guide wire body 1061 is convenient to take out.

Please refer to fig. 3a-3e, which are schematic structural views of an administration port 1023 of the uterine balloon catheter 100 of a medical assembly according to an embodiment of the invention. As shown in fig. 3a-3e, the distal end of uterine balloon catheter 100 is provided with at least one administration port 1023.

Please refer to fig. 4a-4c, which are schematic structural views of the balloon 103 according to an embodiment of the present invention. As shown in fig. 4a-4c, balloon 103 may be a low durometer compliant balloon, which may be spherical, ellipsoidal, or triangular in shape, or other regular or irregular shapes. The different shapes can be suitable for different uterus shapes, such as spherical or triangular shape for common patients, and ellipsoidal shape for postpartum or after pregnancy. The filling volume of balloon 103 is typically set to 2mL-10mL, depending on the uterine volume of the patient, and in special cases, such as after delivery or after pregnancy, the filling volume may be 300mL-600mL, e.g. 500 mL. Balloon 103 may be made of a relatively low durometer (70A-30D) medical grade plastic, such as polyamide, Pebax, polyurethane, PE, PVC, or silicone, or a blend or composite of two or more of these materials.

The operation of the uterine balloon catheter 100 and medical assembly of the present invention is described below in the preferred embodiment shown in fig. 1-4 c.

In operation, balloon 103 is initially in a collapsed state and is loaded with catheter body 102 within sheath 104. In use, the sheath 104 is first advanced into the cervical opening, and then the uterine balloon catheter 100 is slowly advanced forward, supported by the guide wire 106, and the sheath 104 is retracted, exposing the balloon 103 to the uterine cavity. The catheter body 102 is provided with a filling lumen 1021 and an administration lumen 1022. A certain volume of liquid (physiological saline, etc.) or gas (air, etc.) is injected into the balloon 103 through the filling cavity 1021, so that the balloon is filled and deforms in compliance with the uterine cavity structure. Then, the guide wire 106 is pulled out, and the drug (such as a Jinhening drug) is injected from the drug administration cavity 1022, the drug flows out through the drug administration port 1023, and since the outer surface of the balloon 103 is provided with a coating, such as an infiltration coating, the flowed-out drug infiltrates and spreads along the outer surface of the balloon 103 and acts on the endometrium, and the drug administration is relatively uniform.

To sum up, the utility model discloses a uterus sacculus pipe and medical treatment subassembly include the pipe body and are located the sacculus of pipe body distal end, the pipe body has sufficient chamber and the chamber of dosing, sufficient chamber is used for filling the sacculus, the chamber of dosing is used for carrying the medicine extremely the surface of sacculus, the sacculus is sufficient back and uterus inner chamber shape phase-match, can attach in the endometrium, helps evenly dosing and improvement drug utilization rate. In particular, the balloon has a coating configured to match the characteristics of the drug, enabling the drug to diffuse along the outer surface of the balloon, which may further facilitate uniform drug delivery and improve drug utilization. The sacculus is preferably a single-layer sacculus, does not flow through the medicine loss caused by the interlayer, improves the medicine utilization rate, has smaller overall outer diameter after being folded, is easier to pass through the cervical orifice, reduces the probability of cervical injury, and avoids the problem that the interlayer of the double-layer sacculus is compressed to cause difficult administration.

The above description is only for the description of some embodiments of the present invention, and not for any limitation of the scope of the present invention, and any modification and modification made by those skilled in the art according to the above disclosure are all included in the protection scope of the claims.

Claims (11)

1. A uterine balloon catheter is characterized by comprising a catheter body and a balloon, wherein the balloon is arranged at the far end of the catheter body, the catheter body is provided with a filling cavity and a medicine feeding cavity, filling media are conveyed to the balloon through the filling cavity, and medicines are conveyed to the outer surface of the balloon through the medicine feeding cavity; the balloon is matched with the shape of the intrauterine cavity after being inflated.

2. The uterine balloon catheter of claim 1, wherein the balloon is spherical, ellipsoidal, or triangular in shape when inflated.

3. The uterine balloon catheter of any of claims 1-2, wherein an outer surface of the balloon is provided with a coating configured to match characteristics of a drug to cause osmotic diffusion of the drug along the outer surface of the balloon.

4. The uterine balloon catheter of claim 3, wherein the balloon is a single layer balloon, or wherein the balloon is a double layer balloon and the outer surface of the outer layer balloon is provided with the coating.

5. The uterine balloon catheter of claim 1, wherein the distal end of the catheter body is provided with at least one drug delivery port, the drug delivery port communicating with the drug delivery lumen and delivering a drug to the outer surface of the balloon through the drug delivery port.

6. The uterine balloon catheter according to claim 5, wherein when the drug is Jinlinging, the aperture of the administration port is configured to be 1.5mm to 2.0 mm.

7. The uterine balloon catheter according to claim 5, wherein the administration port is plural in number and is arranged at intervals in the axial direction and/or the circumferential direction of the catheter body.

8. A medical assembly comprising the uterine balloon catheter of any of claims 1-7 and a sheath; the uterine balloon catheter is used for loading in the sheath so as to convey the uterine balloon catheter through the sheath.

9. The medical assembly of claim 8, further comprising a fixation member disposed at a proximal end of the sheath for fixing a relative position of the sheath and the catheter.

10. The medical assembly of claim 8, wherein the distal end of the sheath is provided with a graduated marking.

11. The medical assembly of claim 8, further comprising a guidewire including a guidewire body having a length shorter than the uterine balloon catheter and a locking fitting at a proximal end of the guidewire body for preventing a proximal end of the guidewire body from embedding within the uterine balloon catheter.

Images